Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Interventional × Synapsins × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Cisplatin 1306 Carboplatin 1222 Cyclophosphamide 1165 Gemcitabine 1059 Bevacizumab 1056 Paclitaxel 1043 Radiotherapy 1032 Docetaxel 954 pembrolizumab 886 Oxaliplatin 802 Capecitabine 786 Fluorouracil 740 Rituximab 643 Doxorubicin 582 Nivolumab 579 Dexamethasone 577 Etoposide 571 Irinotecan 550 Leucovorin 511 Pemetrexed 436 Drug Therapy 415 Cetuximab 408 Cytarabine 406 Trastuzumab 401 Magnetic Resonance Spectroscopy 386 Filgrastim 384 Prednisone 368 Lenalidomide 351 Bortezomib 347 Temozolomide 342

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡